glp-1 receptor agonists are contraindicated in for individualized treatment of type 2 diabetes mellitus GLP-1 receptor agonists are transforming

Patient reports new heaviness, tightness, or aching not explained by surgical recovery

It is unclear whether using one drug over another yields differences in cardiovascular outcomes

They can have adverse effects including: Hypoglycemia when taken with insulin GI distress Renal insufficiency Pancreatitis Possible risk of thyroid cancer Amylin mimetics Amylin mimetics are a group of medications used to treat type 1 and type 2 diabetes

In other words, youll feel full and wont be driven to eat as much

Acarbose is particularly helpful for individuals who struggle with carbohydrate-heavy diets or have difficulty managing post-meal blood sugar levels

2007;292(5):H207382